chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Strong stomach pain; Brain fog; Shoulder pain; slight fever that rose to 102.5 F; nausea; extreme fatigue; Pain in injection spot; This spontaneous case was reported by a patient (subsequently medically confirmed) and describes the occurrence of ABDOMINAL PAIN (Strong stomach pain), FEELING ABNORMAL (Brain fog), ARTHRALGIA (Shoulder pain), PYREXIA (slight fever that rose to 102.5 F) and NAUSEA (nausea) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 on 30-Mar-2020. Previously administered products included for an unreported indication: SHINGRIX (Slight fever and flu-like symptoms after the second shringrix 50 mcg vaccination.) in January 2020. Concurrent medical conditions included Thyroid disorder NOS since 2002, heart palpitation since 2016, Blood pressure high since 2017 and High cholesterol since 2012. Concomitant products included LOSARTAN and ACETYLSALICYLIC ACID (ASPIRIN 81) for Blood pressure increased, SIMVASTATIN for High cholesterol, LEVOTHYROXINE for Hypothyroidism, ATENOLOL for Palpitations.    On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Jan-2021, the patient experienced ABDOMINAL PAIN (Strong stomach pain), FEELING ABNORMAL (Brain fog), ARTHRALGIA (Shoulder pain), PYREXIA (slight fever that rose to 102.5 F), NAUSEA (nausea), FATIGUE (extreme fatigue) and INJECTION SITE PAIN (Pain in injection spot). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency and IBUPROFEN at an unspecified dose and frequency. On 29-Jan-2021, ABDOMINAL PAIN (Strong stomach pain), FEELING ABNORMAL (Brain fog), ARTHRALGIA (Shoulder pain), PYREXIA (slight fever that rose to 102.5 F), NAUSEA (nausea), FATIGUE (extreme fatigue) and INJECTION SITE PAIN (Pain in injection spot) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 28-Jan-2021, Body temperature: 102.5 f (High) 102.5 F.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       This case was linked to MOD-2021-158001 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 21-May-2021: Vaccine adverse event reporting form was received. Updated medical history, concomitant medications, treatment and events.
Broke out in a rash/ rash started on the arm, then moved literally to all over her body/rash is horrible; This spontaneous case was reported by a consumer and describes the occurrence of RASH (Broke out in a rash/ rash started on the arm, then moved literally to all over her body/rash is horrible) in a 41-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced RASH (Broke out in a rash/ rash started on the arm, then moved literally to all over her body/rash is horrible). At the time of the report, RASH (Broke out in a rash/ rash started on the arm, then moved literally to all over her body/rash is horrible) had not resolved.            It was reported that patient  thought she went for the booster dose, but she is not sure if she received the full dose, it was supposed to be the booster.  No concomitant medication was provided by the reporter. No treatment was provided by the reporter.
On 10 April  I developed pain across the back t the scapular level at about 4 p.m.. At 7 pm the pain was strong to cause me to inhale deeply and bend over but was intermittent. By this time it was radiating around my right side to the middle of my right breast.  By 9 pm the pain was nearly constant an increasing in intensity. All this occurred without any physical activity, we were watching television after dinner. I may have the times a little off  because I was not paying attention to it but to my level of pain.
Loss of hearing in left ear beginning within an hour of the vaccine and lasting over three hours. Facial numbness beginning within an hour of the vaccine and lasting over three hours. Systemic Rash beginning within less than a week of the vaccine and still ongoing with scarring from the hives. New onset of skin reactions to soaps, detergents, deodorants began the same time as systemic rash and occur when using various of these products.
19DEC96 3 days p/vax swollen glands appeared on both sides, more pronounced on lt, tender to touch;t102-103 23DEC-24DEC, 25DEC;quick jerks;
Acute pain and swelling in the first right proximal metatarsophangel joint. Rest, elevation, ice and naprosyn provided relief over the next several days. One recrudescence of symptoms approximately three weeks later of lesser symptomatic severity that responded to rest and naprosyn. Visit to primary physician some time after resolution on June 30 confirmed clinical impression of gouty arthritis of joint as indicated above. Serum uric acid 6.4 mg/dl, normal lab. range 3.5 - 7.2. Prescribed colchicine for use p.r.n. Allopurinol offered as a remedy by not initiated as per patient preference. Hydration, exercise and dietary control are the current therapeutic approaches.
Arm was very sore - went to physician one time -> on 11/14/16 - started soreness -> on 10/31/10. She feels was given into tricep muscle.
The Friday after I developed big red whelps at the injection site. Top of my shoulder to my elbow. It was red, itchy, hot to the touch and sore.
Discharge Provider: MD Primary Care Provider at Discharge: MD  Admission Date: 1/30/2023 Discharge Date: ?2/1/2023   PRESENTING PROBLEM: DKA, type 1, not at goal  Diabetic ketoacidosis without coma associated with type 1 diabetes mellitus COVID-19    HOSPITAL COURSE: Patient is a 53-year-old woman with complex past medical history including type 1 diabetes with insulin pump, combined heart failure, hypertension, atrial fibrillation, coronary artery disease status post stenting who presented with 2 weeks of upper respiratory infection symptoms and difficulty monitoring her blood sugars.  Patient's Dexcom meter malfunctioned and she did not have any more sensors at home.  She was unable to refill the sensors early.  She still continued to use her insulin pump, but was unable to check sugars at all because her home fingerstick glucometer was out of batteries.  She stated that life was busy lately and she did not have time to get batteries for the glucometer.  When she presented to the emergency department her blood glucose was 525, pH was 7.07, beta hydroxybutyrate greater than 9, and bicarbonate of 7. She was found to be COVID positive.  Patient was admitted to the intensive care unit for insulin drip.  She required electrolyte replacement on the drip and was also given IV fluids.  Patient was taken off the insulin drip and transitioned to subcutaneous Lantus 15 units in the early afternoon on 01/31.  Her blood sugars remained well controlled and by the following day she was feeling well. She was set up with a new glucometer and discharged on basal bolus insulin. She has an appointment with her endocrinologist next week and was encouraged to keep that appointment and to follow up with her PCP after discharge. The patient verbalized understanding of these instructions and discharged home in stable condition.
09/21/2021 I had my vaccination. I had surgery 03/08/2022 to repair ligaments in my knee. My knee was immediately swollen just after surgery. It went down for 3 to 4 weeks but then started to swell again. There was no remnant of the graft left at all and no tissue left. I had a MRI and second surgery on 08/01/2022. I had my second booster on 05/17/2022.
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
Tingle of pain; pain at injection site; This spontaneous case was reported by a consumer and describes the occurrence of PARAESTHESIA (Tingle of pain) and VACCINATION SITE PAIN (pain at injection site) in a 76-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 18-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Jan-2021, the patient experienced PARAESTHESIA (Tingle of pain) and VACCINATION SITE PAIN (pain at injection site). On 19-Jan-2021, PARAESTHESIA (Tingle of pain) had resolved. On 20-Jan-2021, VACCINATION SITE PAIN (pain at injection site) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported. Treatment information was not provided
couldn't sleep at all; rapid heartbeat at a maximum of 100bpm; felt lightheaded; mild allergic reaction described as really bad chills for about 2 hours; This spontaneous case was reported by a consumer and describes the occurrence of INSOMNIA (couldn't sleep at all), HEART RATE IRREGULAR (rapid heartbeat at a maximum of 100bpm), DIZZINESS (felt lightheaded) and CHILLS (mild allergic reaction described as really bad chills for about 2 hours) in a 36-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 042B21A and 001B21A) for COVID-19 vaccination.     no medical history information was reported.    On 15-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 12-Apr-2021, the patient experienced INSOMNIA (couldn't sleep at all), HEART RATE IRREGULAR (rapid heartbeat at a maximum of 100bpm), DIZZINESS (felt lightheaded) and CHILLS (mild allergic reaction described as really bad chills for about 2 hours). The patient was treated with PARACETAMOL (TYLENOL) on 13-Apr-2021 at a dose of 2 dosage form. On 13-Apr-2021, HEART RATE IRREGULAR (rapid heartbeat at a maximum of 100bpm) had resolved. At the time of the report, INSOMNIA (couldn't sleep at all) outcome was unknown and DIZZINESS (felt lightheaded) and CHILLS (mild allergic reaction described as really bad chills for about 2 hours) was resolving.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 12-Apr-2021, Heart rate: 100bpm (High) maximum of 100bpm.         No relevant concomitant medications were reported. The patient received both scheduled doses of mRNA-1273 prior to the events; therefore, action taken with the drug in response to the events is not applicable. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   This case was linked to US-MODERNATX, INC.-MOD-2021-074863 (Patient Link).
sore arm; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP), . The reporter is the patient.  A male patient received BNT162b2 (BNT162B2), as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (dose 1, single), for COVID-19 immunization, reaction(s): "Sore arm". The following information was reported: PAIN IN EXTREMITY (non-serious), outcome "unknown", described as "sore arm".  Additional information: The reporter mentioned that he and his wife took the initial Pfizer COVID vaccine and the bivalent COVID vaccine last Oct and had a sore arm. His wife started taking Miralax (propylene glycol) and possibly had a reaction to it. He wants to know if vaccines have the same product.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202300180212 same patient/vaccine/event; different dose;
Extremely heavy menstrual bleeding following a strenuous hike.  This was 4 days post 2nd CoVID 19 vaccination.  Extreme fatigue for 6-8 hours after cycle.  After initial bleeding period of 2 hours.  Cycle returned to typical flow.
severe neck pain that developed about 10-12 hours after injection.  Pain was debilitating and last for about 36 hours. Unable to move neck or lift arm.
runny nose off/on; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP).  A male patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 10Feb2023 as dose number unknown (booster), single (Lot number: GJ3277) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (DOSE 1, SINGLE), for Covid-19 immunization; Covid-19 vaccine (DOSE 2, SINGLE , MANUFACTURER UNKNOWN), for Covid-19 immunization. The following information was reported: RHINORRHOEA (non-serious) with onset 14Feb2023, outcome "unknown", described as "runny nose off/on".; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021351166 Same patient, different vaccine dose number and different event.;
(R) arm swelling with erythema dx'd with cellulitis and Rx'd with clindamycin.
Information has been received from a healthcare worker referring to a patient of unknown age and gender. On 30-APR-2015 the patient was vaccinated with a dose of improperly stored (Oka/Merck) VARIVAX lot # K021936, expiration date: 10-NOV-2016, subcutaneous, dose was not reported). No adverse effects were reported. This is one of several reports received from the same reporter. Additional information has been requested.
symptom: chest pain, pain in my left arm approximately 4 inches from my arm pit (injection side), shortness of breath, heart felt as though rhythm was off a bit. This happened about three days after my first dose for about 4 days. Starting to feel better now though. I didn't know what was happening and was tempted to go to the emergency room a couple of times but didn't. I'm just finding out about this from an article I'm just reading about 30 minutes ago and thought I should report this. I've only had my first dose and now I'm very concerned about the second due June 22nd.
arm hurt a little bit; Very tired; slept a lot; headache; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (headache), PAIN IN EXTREMITY (arm hurt a little bit), FATIGUE (Very tired) and SLEEP DISORDER (slept a lot) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided by the reporter.    On 30-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 27-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 03-Mar-2021, the patient experienced HEADACHE (headache). On an unknown date, the patient experienced PAIN IN EXTREMITY (arm hurt a little bit), FATIGUE (Very tired) and SLEEP DISORDER (slept a lot). On 04-Mar-2021, HEADACHE (headache) had resolved. At the time of the report, PAIN IN EXTREMITY (arm hurt a little bit), FATIGUE (Very tired) and SLEEP DISORDER (slept a lot) outcome was unknown.            This case was linked to MOD-2020-036191, MOD-2021-034961 (E2B Linked Report).; Sender's Comments:  MOD-2020-036191: MOD-2021-034961:
Left arm where I got shot started to sore quickly. No other symptoms when I went to bed. Woke up next morning with extreme fatigue, pain to the left underarm, chill, head felt heavy. I took ibuprofen.  I believe I run fever later on but I don't have a thermometer so can't be sure but my body got  hot. No appetite in the morning but I could eat light meal in the afternoon. Fatigue and headache lasted to the evening. I took ibuprofen every 4 hours and slept with ice pillow. I was not 100% around 10pm, but when I woke up next morning I was fine.
Malaise; Injection site pain; Nausea; Headache; This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (Malaise), VACCINATION SITE PAIN (Injection site pain), NAUSEA (Nausea) and HEADACHE (Headache) in a 55-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 007M20A and 030Q21A) for COVID-19 vaccination.     The patient's past medical history included Breast cancer (Left Breast cancer), Premature ventricular contractions and Hysterectomy. Previously administered products included for Breast cancer: Tamoxifen. Family history included Autoimmune disorder since an unknown date.   On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 05-Feb-2021, the patient experienced MALAISE (Malaise), VACCINATION SITE PAIN (Injection site pain), NAUSEA (Nausea) and HEADACHE (Headache). At the time of the report, MALAISE (Malaise), VACCINATION SITE PAIN (Injection site pain), NAUSEA (Nausea) and HEADACHE (Headache) had resolved.        mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing remained unchanged.       No relevant concomitant medications were reported.   Treatment information was not provided.    This case was linked to MOD-2021-216657 (Patient Link).
Parent brought child to a vaccination clinic and requested an influenza vaccination.  No access to system, but when entered a few days later it was discovered the child had received a vaccine two days previously at a local pharmacy.
Symptoms : sensation that your throat was closing, that I could not breath, I could not swallow, flushed face, increased heart rate, pain down left arm, weakness  Treatment:Epinephrine given at 12:00 PM, Epinephrine given at 12:15 PM, MethlylPrednisone sodium succinate (solumedrol) given at 12:00PM, Diphenhydramine given at 12:02 PM, Ondansetron given at 12:20,Famotidine given at 12:01PM, Sodium Chloride 0.9% Stopped at 3:00PM EKG  Discharge 4:45
Diagnosed with Bell's Palsy.  My face paralyzed and droops on the left side .  My eye, mouth, and all facial muscles on the left side are weak and won't move.  My tongue felt numb and and I have no sense of taste. I have a hard time talking because the left side of my mouth doesn't move.  My eye is watering a lot and I can't shut my left eyelid all the way.  I have headaches and jaw pain.  I went to the ER and then to my primary doctor and was given an antiviral medicine and prednisone. I am still currently having all of these symptoms and the jaw pain is worse.
Site of vaccination began itching about one week after injection.  A red area surrounding the injection site was noted about 3 days later. Itching is insignificant, and the arm is otherwise completely normal.   Since it is now about 10 days after the injection, I don't know how long it will take before the rash disappears.
tingling and numbness started going down into her arm; tingling and numbness started going down into her arm; soreness at the injection site; numbness where the injection site was on her arm; Tingling; This non-serious case was reported by a consumer via call center representative and described the occurrence of injection site numbness in a 66-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 12-APR-2023, the patient received the 2nd dose of Shingrix (left arm). On 12-APR-2023, immediately after receiving Shingrix, the patient experienced injection site pain (Verbatim: soreness at the injection site). In APR-2023, the patient experienced injection site numbness (Verbatim: numbness where the injection site was on her arm) and injection site tingling (Verbatim: Tingling). On an unknown date, the patient experienced tingling (Verbatim: tingling and numbness started going down into her arm) and numbness (Verbatim: tingling and numbness started going down into her arm). The outcome of the injection site numbness, injection site tingling, injection site pain, tingling and numbness were not resolved.   It was unknown if the reporter considered the injection site numbness, injection site tingling, injection site pain, tingling and numbness to be related to Shingrix.   It was unknown if the company considered the injection site numbness, injection site tingling, injection site pain, tingling and numbness to be related to Shingrix.   Additional Information: GSK Receipt date: 05-JUN-2023 The reporter reported that from the time of her injection, and for several weeks after the injection (no exact date provided), she had soreness at the injection site. About 2 weeks after the injection (may be longer she said as no exact date provided), she was still experiencing the soreness at the injection site, and also started having tingling and numbness where the injection site was on her arm. This tingling and numbness started going down into her arm and hand a few days after it started at the injection site (no exact date provided). The patient did not have any exact dates for any of her adverse reactions. Consent to follow up with HCP was obtained.
Pt fainted after administration, pt sat down & drank water and got up and left. We call 911 but pt refused further help. Called pt at 1pm & he was fine.
Heart Attack approximately 20-30 minutes after receiving 2nd dose.  8 days in Hospital  1or 2 days on a ventilator 4 stents  initially then 6 more stents put in to me at beginning of May
Received nasal mist on 10/15/09. Developed fever on 10/17, vomited, has not had cough. Fevers up to 103.9, currently day 4 of fevers.
Patient received MCV and Influenza on (L) deltoid, left arm swelling and redness.
Patient ran a high fever the day after recieving vaccine.  He had the fever on 11/7 through 11/10 and seemed to break as of earlier today he treated the fever with Tylenol.
Strong soreness from the region where the shot was given for at least two days. Roughly one-third of my upper arm was involved. It took another three or four days for the pain to completely disappear.
High Fever 103.5 Chills Headache General Joint pain  Vomiting
Inpatient admission to hospital with symptoms thought to be consistent with "COVID encephalopathy"
About 5 minutes after receiving her pfizer booster the patient fainted.  She fell forward off of her chair onto the ground, she remained unconscious for about 60 seconds.  Upon awakening she reported that she felt like she hit her head.  She claimed that she was feeling fine, other than the small bump on her head.  She was monitored for about 20 minutes before a friend picked her up to take her home.
Tiredness; muscle pain,; headache; This case was reported by a consumer via call center representative and described the occurrence of tiredness in a 51-year-old patient who received Herpes zoster (Shingrix) for prophylaxis.   On 18th March 2020, the patient received Shingrix. In March 2020, less than a week after receiving Shingrix, the patient experienced tiredness, muscle pain and headache. On an unknown date, the outcome of the tiredness, muscle pain and headache were unknown.   It was unknown if the reporter considered the tiredness, muscle pain and headache to be related to Shingrix.  Additional details were provided as follows: The reporter wanted to know that how long these typical side effects last.